Skip to content

Evaluation of Lifestyle Education and Events Via Network Text Messages After Acute Coronary Syndrome

Evaluation of Lifestyle Education and Events Via Network Text Messages After Acute Coronary Syndrome (Elena Trial)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07331415
Acronym
Elena
Enrollment
370
Registered
2026-01-09
Start date
2019-05-01
Completion date
2023-03-01
Last updated
2026-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Cardiovascular Diseases, Myocardial Infarction

Keywords

Text messaging, Usual care

Brief summary

To evaluate the usefulness of telephone text messages (TTM) in the control of risk factors and in the reduction of events in the first year after an ACS (acute coronary syndrome).

Detailed description

To evaluate the usefulness of telephone text messages (TTM) in the control of risk factors and in the reduction of events in the first year after an ACS (acute coronary syndrome).

Interventions

OTHERText messaging and Usual Care

The patient received a monthly telephone text messages (TTM) for 12 months with the recommendations of the Spanish Society of Cardiology regarding secondary prevention and followed the usual review protocol in a specific ischemic heart disease consultation at 3 and 12 months after discharge.

BEHAVIORALUsual Care

The patient received followed the usual review protocol in a specific ischemic heart disease consultation at 3 and 12 months after discharge.

Sponsors

Fundación EPIC
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients discharged with ACS and without ST elevation. * Informed consent signed.

Exclusion criteria

* Refusal to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Composite of cardiac death, myocardial infarction, stroke or new revascularization12 monthsOccurrence of Composite of cardiac death, myocardial infarction, stroke or new revascularization

Secondary

MeasureTime frameDescription
Diastolic blood pressure (DBP) (mm Hg)12 monthsMean of DBP
Change in Weight (kilograms)12 monthsMean of Change in Weight
Low Density Lipoproteins (LDL) cholesterol (mg/dl)12 monthsMean of LDL
High (HDL) cholesterol (mg/dl)12 monthsMean of LDL
Triglycerides (mg/dl)12 monthsMean of Triglycerides
Glycosylated hemoglobin (%)12 monthsMean of Glycosylated hemoglobin
Systolic blood pressure (SBP) mm Hg12 monthsMean of SBP
Exercise per week (hours)12 monthsMean of Exercise per week
Total Death12 monthsOccurrence of All Death
Cardiac Death12 monthsOccurrence of Cardiovascular Death
Myocardial Infarction12 monthsOccurrence of Myocardial Infarction
Stroke12 monthsOccurrence of Stroke
New revascularization12 monthOccurrence of New revascularization
Active smoking12 monthsPercentage of Active smoking

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026